St. Luke's Cancer Institute: Boise — Boise, Idaho

St. Luke's Cancer Institute: Boise is a clinical research site located in Boise, Idaho, United States 83712.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Luke's Cancer Institute: Boise has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Pancreatic Ductal Adenocarcinoma, Breast Cancer.

Sponsors: Bristol-Myers Squibb, Pfizer, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Cancer Institute: Boise?

St. Luke's Cancer Institute: Boise has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Cancer Institute: Boise conducted?

St. Luke's Cancer Institute: Boise has 4 clinical trials on record, with 4 currently active. Their work covers Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Pancreatic Ductal Adenocarcinoma, Breast Cancer.

Is St. Luke's Cancer Institute: Boise accredited by Crixeo Health?

St. Luke's Cancer Institute: Boise has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Cancer Institute: Boise?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.